Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy

Ginsberg, H. N., Hounslow, N. J., Senko, Y., Suganami, H., Bogdanski, P., Ceska, R., Kalina, A., Libis, R. A., Supryadkina, T. V., & Hovingh, G. K. (2022). Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy. Diabetes Care, 45(4), 898–908. https://doi.org/10.2337/dc21-1288

Authors:

Henry N. Ginsberg

Neil J. Hounslow

Yusuke Senko

Hideki Suganami

Pawel Bogdanski

Richard Ceska

Akos Kalina

Roman A. Libis

Tatiana V. Supryadkina

G. Kees Hovingh

Affiliated Authors: